George Budwell
George Budwell, PhD, is a contributing Motley Fool biotechnology and technology analyst covering disruptive innovators in healthcare, defense, and artificial intelligence. He also writes on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer and a consultant for several life sciences hedge funds. Earlier in his career, he was an evolutionary biologist and completed postdoctoral fellowships at Kyoto University and Illinois State University. He holds a doctorate in evolutionary biology from Tulane University and a bachelor’s degree from Loyola University.
Recent Articles by George Budwell

Better Quantum Computing Stock: IonQ vs. Alphabet

Better Artificial Intelligence Stock: Nvidia vs. ASML

Why Archer Aviation Is My Top Stock Pick for 2025

2 Top AI Stocks I'm Buying on the Dip

3 Best AI Stocks to Buy in February

Is $20 in Sight for Archer Aviation Stock This Year?

2 Elite Dividend Growth Stocks I'm Buying on the Dip

3 Quantum Computing Stocks I'm Buying on the Dip

Is Vertex Pharmaceuticals Stock a Buy in 2025?
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.